Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) shares were down 2.7% on Thursday . The company traded as low as €22.90 ($24.89) and last traded at €23.00 ($25.00). Approximately 3,641,389 shares traded hands during trading, The stock had previously closed at €23.64 ($25.70).
Bayer Aktiengesellschaft Trading Up 1.7 %
The firm has a market capitalization of $23.51 billion, a PE ratio of -26.71, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The business’s 50 day simple moving average is €21.59 and its two-hundred day simple moving average is €23.26.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Read More
- Five stocks we like better than Bayer Aktiengesellschaft
- How to Invest in the FAANG Stocks
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Use Stock Screeners to Find Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Choose Top Rated Stocks
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
